152 related articles for article (PubMed ID: 16387492)
1. Structural modifications of the cannabinoid side chain towards C3-aryl and 1',1'-cycloalkyl-1'-cyano cannabinoids.
Papahatjis DP; Nahmias VR; Andreou T; Fan P; Makriyannis A
Bioorg Med Chem Lett; 2006 Mar; 16(6):1616-20. PubMed ID: 16387492
[TBL] [Abstract][Full Text] [Related]
2. C1'-cycloalkyl side chain pharmacophore in tetrahydrocannabinols.
Papahatjis DP; Nahmias VR; Nikas SP; Andreou T; Alapafuja SO; Tsotinis A; Guo J; Fan P; Makriyannis A
J Med Chem; 2007 Aug; 50(17):4048-60. PubMed ID: 17672444
[TBL] [Abstract][Full Text] [Related]
3. Pharmacophoric requirements for the cannabinoid side chain. Probing the cannabinoid receptor subsite at C1'.
Papahatjis DP; Nikas SP; Kourouli T; Chari R; Xu W; Pertwee RG; Makriyannis A
J Med Chem; 2003 Jul; 46(15):3221-9. PubMed ID: 12852753
[TBL] [Abstract][Full Text] [Related]
4. Exploring the substituent effects on a novel series of C1'-dimethyl-aryl Delta8-tetrahydrocannabinol analogs.
Krishnamurthy M; Gurley S; Moore BM
Bioorg Med Chem; 2008 Jul; 16(13):6489-500. PubMed ID: 18524604
[TBL] [Abstract][Full Text] [Related]
5. Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols.
Papahatjis DP; Kourouli T; Abadji V; Goutopoulos A; Makriyannis A
J Med Chem; 1998 Mar; 41(7):1195-200. PubMed ID: 9544219
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
Rao GK; Kaminski NE
J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
[TBL] [Abstract][Full Text] [Related]
7. Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors.
Hanus LO; Tchilibon S; Ponde DE; Breuer A; Fride E; Mechoulam R
Org Biomol Chem; 2005 Mar; 3(6):1116-23. PubMed ID: 15750656
[TBL] [Abstract][Full Text] [Related]
8. Unsaturated side chain beta-11-hydroxyhexahydrocannabinol analogs.
Busch-Petersen J; Hill WA; Fan P; Khanolkar A; Xie XQ; Tius MA; Makriyannis A
J Med Chem; 1996 Sep; 39(19):3790-6. PubMed ID: 8809166
[TBL] [Abstract][Full Text] [Related]
9. The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2.
Durdagi S; Kapou A; Kourouli T; Andreou T; Nikas SP; Nahmias VR; Papahatjis DP; Papadopoulos MG; Mavromoustakos T
J Med Chem; 2007 Jun; 50(12):2875-85. PubMed ID: 17521177
[TBL] [Abstract][Full Text] [Related]
10. Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9-tetrahydrocannabinol.
Buchweitz JP; Karmaus PW; Williams KJ; Harkema JR; Kaminski NE
J Leukoc Biol; 2008 Mar; 83(3):785-96. PubMed ID: 18073275
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
[TBL] [Abstract][Full Text] [Related]
12. One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors.
Rosati O; Messina F; Pelosi A; Curini M; Petrucci V; Gertsch J; Chicca A
Eur J Med Chem; 2014 Oct; 85():77-86. PubMed ID: 25072877
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors.
Braun A; Engel T; Aguilar-Pimentel JA; Zimmer A; Jakob T; Behrendt H; Mempel M
Immunobiology; 2011 Apr; 216(4):466-76. PubMed ID: 21056512
[TBL] [Abstract][Full Text] [Related]
14. Potent cyano and carboxamido side-chain analogues of 1', 1'-dimethyl-delta8-tetrahydrocannabinol.
Singer M; Ryan WJ; Saha B; Martin BR; Razdan RK
J Med Chem; 1998 Oct; 41(22):4400-7. PubMed ID: 9784115
[TBL] [Abstract][Full Text] [Related]
15. Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor.
Deng H; Gifford AN; Zvonok AM; Cui G; Li X; Fan P; Deschamps JR; Flippen-Anderson JL; Gatley SJ; Makriyannis A
J Med Chem; 2005 Oct; 48(20):6386-92. PubMed ID: 16190764
[TBL] [Abstract][Full Text] [Related]
16. Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists.
Martin BR; Jefferson R; Winckler R; Wiley JL; Huffman JW; Crocker PJ; Saha B; Razdan RK
J Pharmacol Exp Ther; 1999 Sep; 290(3):1065-79. PubMed ID: 10454479
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors.
Govaerts SJ; Hermans E; Lambert DM
Eur J Pharm Sci; 2004 Nov; 23(3):233-43. PubMed ID: 15489124
[TBL] [Abstract][Full Text] [Related]
18. Enantioselective synthesis of 1-methoxy- and 1-deoxy-2'-methyl-delta8-tetrahydrocannabinols: new selective ligands for the CB2 receptor.
Huffman JW; Bushell SM; Joshi SN; Wiley JL; Martin BR
Bioorg Med Chem; 2006 Jan; 14(1):247-62. PubMed ID: 16165365
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.
Song KS; Lee SH; Chun HJ; Kim JY; Jung ME; Ahn K; Kim SU; Kim J; Lee J
Bioorg Med Chem; 2008 Apr; 16(7):4035-51. PubMed ID: 18243711
[TBL] [Abstract][Full Text] [Related]
20. Delta(9)-Tetrahydrocannabinol enhances MCF-7 cell proliferation via cannabinoid receptor-independent signaling.
Takeda S; Yamaori S; Motoya E; Matsunaga T; Kimura T; Yamamoto I; Watanabe K
Toxicology; 2008 Mar; 245(1-2):141-6. PubMed ID: 18249480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]